SCHEMBL13699670

SCHEMBL13699670

Cc1cccc2c(N)c(C(N)=O)oc12

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 2/20 0.57
KDM4E B2RXH2 7/20 0.43
HPGD P15428 3/20 0.43
ALDH1A1 P00352 2/20 0.43
HSD17B10 Q99714 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 3/20 0.40
MAPT P10636 3/20 0.40
RAB9A P51151 2/20 0.40
AHR P35869 1/20 0.40
KMT2A Q03164 3/20 0.37
IKBKB O14920 1/20 0.37
MEN1 O00255 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SLC9A1 P19634 1/20 0.35
PRKDC P78527 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
LCK P06239 1/20 0.35
BTK Q06187 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11127156 0.83 MCL1 (0.57) MCL1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL10430027 0.80 KDM4E (0.66) MCL1KDM4EHPGDALDH1A1HSD17B10
Bromide SCHEMBL4256896 0.80 KDM4E (0.43) MCL1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL4251368 0.80 ALDH1A1 (0.51) KDM4EHPGDALDH1A1HSD17B10SMN1; SMN2
SCHEMBL13699676 0.76 CYP1A2 (0.44) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL13699673 0.75 HPGD (0.55) KDM4EHPGDALDH1A1HSD17B10NPC1
SCHEMBL1852098 0.74 HSD17B10 (0.41) MCL1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL20534983 0.73 MAPT (0.44) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL11748492 0.72 MCL1 (1.00) MCL1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL20526911 0.72 MCL1 (0.75) MCL1KDM4EHPGDALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F MCL1 2744/4885KDM4E 4227/4885HPGD 3251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.